<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Insulet Corporation

    Insulet Corporation

    Insulet Corporation is an innovative medical device company based in Acton, Massac...

    Insulet Corporation is an innovative medical de...

    Filing Type:    PU
    AnaptysBio, Inc.

    AnaptysBio, Inc.

    AnaptysBio is a clinical-stage antibody development company advancing therapeutic ...

    AnaptysBio is a clinical-stage antibody develop...

    Filing Type:    PU
    Tribal LLC

    Tribal LLC

    We believe clean and healthy skin, hair and teeth can be achieved with far fewer p...

    We believe clean and healthy skin, hair and tee...

    Amount Raised:    $92,195.00
    Fundraising Status:    EC
    Filing Type:    CF
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and ...

    Catalyst Pharmaceuticals is a biopharmaceutical...

    Filing Type:    PU
    VIVUS, Inc.

    VIVUS, Inc.

    With demonstrated clinical development and commercialization expertise, VIVUS is d...

    With demonstrated clinical development and comm...

    Filing Type:    PU
    MEI Pharma, Inc.

    MEI Pharma, Inc.

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based late-stage pharmaceutical company f...

    MEI Pharma (Nasdaq: MEIP) is a San Diego-based ...

    Filing Type:    PU
    bluebird bio, Inc.

    bluebird bio, Inc.

    bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., h...

    bluebird bio is pioneering gene therapy with pu...

    Filing Type:    PU
    ViewRay, Inc.

    ViewRay, Inc.

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdianÂŽ the wor...

    ViewRayÂŽ Inc., (NASDAQ:VRAY), designs, manufac...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.